Am I eligible for this trial based on my cancer type and treatment history?

This is a question you may want to discuss with your doctor regarding the Tislelizumab in People With Colorectal Cancer clinical trial (NCT06529523). Contact the study team or your healthcare provider for specific answers.

What are the potential side effects of tislelizumab?

This is a question you may want to discuss with your doctor regarding the Tislelizumab in People With Colorectal Cancer clinical trial (NCT06529523). Contact the study team or your healthcare provider for specific answers.

How does this treatment compare to other options available for my condition?

This is a question you may want to discuss with your doctor regarding the Tislelizumab in People With Colorectal Cancer clinical trial (NCT06529523). Contact the study team or your healthcare provider for specific answers.

What will the treatment schedule look like, and how often will I need to come in for visits?

This is a question you may want to discuss with your doctor regarding the Tislelizumab in People With Colorectal Cancer clinical trial (NCT06529523). Contact the study team or your healthcare provider for specific answers.

What happens if I experience side effects during the trial?

This is a question you may want to discuss with your doctor regarding the Tislelizumab in People With Colorectal Cancer clinical trial (NCT06529523). Contact the study team or your healthcare provider for specific answers.

How will my progress be monitored during the study?

This is a question you may want to discuss with your doctor regarding the Tislelizumab in People With Colorectal Cancer clinical trial (NCT06529523). Contact the study team or your healthcare provider for specific answers.

Finding studies

Back

Tislelizumab in People With Colorectal Cancer

NCT065295233 sitesClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | Tislelizumab in People With Colorectal Cancer